You are here

CHAPLE disease

Regeneron’s Antibody Gets FDA Approval for Ultra-Rare Hereditary Disease

Regeneron’s Antibody Gets FDA Approval for Ultra-Rare Hereditary Disease

BioSpace

Flag link:

FDA Action Alert: Ipsen, Revance, Neurocrine and Regeneron

FDA Action Alert: Ipsen, Revance, Neurocrine and Regeneron

BioSpace

Revance Therapeutics

fibrodysplasia ossificans progressiva

cervical dystonia

Huntington's disease

Flag link:

5 Highly Anticipated FDA Decisions for Rare Diseases Coming This Year

5 Highly Anticipated FDA Decisions for Rare Diseases Coming This Year

BioSpace

fibrodysplasia ossificans progressiva

Santhera Pharmaceuticals

Flag link: